STAT Plus Pharmalittle Bluebird Bio prices gene therapy at $1.8 million; lawmakers urge feds to step up generic probe

STAT Plus: Pharmalittle: Bluebird Bio prices gene therapy at $1.8 million; lawmakers urge feds to step up generic probe

Citing 'polite f-u letters,' two lawmakers urged the Department of Justice to step up its probe of generic drug makers and whether they colluded to avoid their 2014 inquiry.

More From BioPortfolio on "STAT Plus: Pharmalittle: Bluebird Bio prices gene therapy at $1.8 million; lawmakers urge feds to step up generic probe"